This case emphasizes the challenges in diagnosing and treating Prostatic Duct Adenocarcinoma, especially in resource-limited settings. Early and accurate diagnosis is crucial for better patient outcomes, but limited access to advanced diagnostics and specialized treatments significantly hinders the effective management of this aggressive form of prostate cancer.
Keywords: androgen deprivation therapy; chemotherapy; metastases; prostate cancer; prostatic ductal adenocarcinoma; radiotherapy.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.